Meta Information

ID:nicotine-non-tobacco

Name:Nicotine (Non-Tobacco)

Schema Version:1.5

Alternate Names

• Nicotine Polacrilex

Intervention Type

therapeutic_agent

Expected Cost Mean

Low Cost:

15

High Cost:

40

Cost Type:

monthly

Description:

Over-the-counter patches, gums, or lozenges.

Summary

Nicotine is a nicotinic acetylcholine receptor (nAChR) agonist known for its cognitive-enhancing effects. Its relevance to healthspan is speculative, based on preclinical evidence suggesting it may offer neuroprotection against diseases like Parkinson's and Alzheimer's by reducing neuroinflammation and promoting cell survival. However, these potential benefits must be weighed against its significant addictive potential and cardiovascular risks.

Purpose

A cognitive enhancer and potential neuroprotectant via nAChR agonism.

Card Summary

A highly addictive cognitive enhancer with speculative neuroprotective benefits and known cardiovascular risks.

Drug Class

Nicotinic Acetylcholine Receptor Agonist

Drugs In Class

Empty Array

Impact

Score:

2.8

Justification:

Primarily a short-term cognitive enhancer with unproven long-term healthspan benefits.

Evidence

Grade:

C

Score:

3.5

Justification:

Human cognitive data exists, but healthspan and neuroprotective evidence is mostly preclinical.

Safety

Score:

6.8

Justification:

High addiction potential and known cardiovascular risks like increased heart rate and blood pressure.

Flags

• Highly addictive, with a significant risk of psychological and physical dependence.
• Can acutely increase heart rate, blood pressure, and risk of cardiovascular events.
• Not recommended for individuals with pre-existing cardiovascular conditions, hypertension, or arrhythmias.
• May impair insulin sensitivity over the long term.
• Use during pregnancy is associated with adverse developmental effects.

Verdict

High-risk cognitive tool with unproven benefits for overall healthspan.

Created

2026-04-27T00:53:01.463464Z

Model

Gemini 3.1 Pro (High)

Delivery

Route:

transdermal_patch

Scope:

• systemic

Indication

Focus:

healthspan

Description:

Nicotine is a nicotinic acetylcholine receptor (nAChR) agonist known for its cognitive-enhancing effects. Its relevance to healthspan is speculative, based on preclinical evidence suggesting it may of...

Typical Protocol

• Use 1-2mg of nicotine gum or lozenge as needed for acute cognitive focus.
• Apply a low-dose transdermal patch (e.g., 3.5mg) daily for sustained, low-level exposure.